ArticleMolecular medicine (Cambridge, Mass.)2020

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.

Christoph Fraune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.